Origins of MCL genes
Tier 1 MCL genes
| Gene | Status | First MCL study | Other lists |
|---|---|---|---|
| ATM | MCL Tier 1 | Bea et al | DLBCL, MZL |
| BIRC3 | MCL Tier 1 | Bea et al | DLBCL, MZL, PMBL |
| CARD11 | MCL Tier 1 | Wu et al | DLBCL, MZL, FL, BL |
| CCND1 | MCL Tier 1 | Bea et al | |
| DAZAP1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| EWSR1 | MCL Tier 1 | Pararajalingam et al | PMBL |
| HNRNPH1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| KMT2D | MCL Tier 1 | Bea et al | FL, BL, DLBCL, PMBL, MZL |
| MEF2B | MCL Tier 1 | Bea et al | FL, DLBCL |
| NFKBIE | MCL Tier 1 | Pararajalingam et al | DLBCL, PMBL |
| NOTCH1 | MCL Tier 1 | Bea et al | MZL, DLBCL, BL |
| NOTCH2 | MCL Tier 1 | Bea et al | MZL, DLBCL |
| NSD2 | MCL Tier 1 | Bea et al | DLBCL |
| POT1 | MCL Tier 1 | Zhang et al | |
| RB1 | MCL Tier 1 | Zhang et al | DLBCL |
| S1PR1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| SMARCA4 | MCL Tier 1 | Nadeu et al | DLBCL, BL, FL, PMBL |
| SP140 | MCL Tier 1 | Bea et al | |
| SYNE1 | MCL Tier 1 | Nadeu et al | |
| TERT | MCL Tier 1 | Nadeu et al | |
| TLR2 | MCL Tier 1 | Bea et al | DLBCL |
| TP53 | MCL Tier 1 | Bea et al | PMBL, DLBCL, FL, BL, MZL |
| UBR5 | MCL Tier 1 | Pararajalingam et al | DLBCL |
Tier 2 MCL genes
References
1.
Jallades L, Baseggio L, Sujobert P, Huet S,
Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado
D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles
G, Traverse-Glehen A. Exome sequencing identifies recurrent
BCOR alterations and the absence of KLF2,
TNFAIP3 and MYD88 mutations in splenic diffuse
red pulp small B-cell lymphoma.
Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
2.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love
CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg
ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W,
Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y,
Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O,
Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB,
Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava
G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn
A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T,
Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional
Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017
Oct;171(2):481–494.e15. PMCID: PMC5659841
3.
Morin RD, Mungall K, Pleasance E, Mungall AJ,
Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC,
Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A,
Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL,
Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors
JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse
large B-cell lymphoma using whole-genome
sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
4.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S,
Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier
DG, Strefford JC. Whole exome sequencing identifies novel recurrently
mutated genes in patients with splenic marginal zone lymphoma. PLoS One.
2013;8(12):e83244. PMCID: PMC3862727
5.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata
K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW,
Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A,
Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW,
Traverse-Glehen A, Steidl C. Mutational landscape of
gray zone lymphoma. Blood. 2021 Apr 1;137(13):1765–1776.
6.
Zhang J, Grubor V, Love CL, Banerjee A,
Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G,
Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C,
Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A,
Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J,
Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse
large B-cell lymphoma. Proceedings of the
National Academy of Sciences of the United States of America.
2013;110:1398–1403. PMCID: PMC3557051
7.
Zhou
P, Blain AE, Newman AM, Zaka M, Chagaluka G, Adlar FR, Offor UT,
Broadbent C, Chaytor L, Whitehead A, Hall A, O’Connor H, Van Noorden S,
Lampert I, Bailey S, Molyneux E, Bacon CM, Bomken S, Rand V. Sporadic
and endemic Burkitt lymphoma have frequent
FOXO1 mutations but distinct hotspots in the
AKT recognition motif. Blood Adv. 2019 Jul
23;3(14):2118–2127. PMCID: PMC6650741
8.
Spina V, Khiabanian H, Messina M, Monti S,
Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni
M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni
M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B,
Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The
genetics of nodal marginal zone lymphoma. Blood. 2016 Sep
8;128(10):1362–1373. PMCID: PMC5016706
9.
Love
C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi
WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L,
Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader
MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A,
Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations
in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325.
PMCID: PMC3674561


